RE
IART icon

RBC Europe’s Integra LifeSciences IART Stock Holding History

RBC Europe’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-178
Closed -$12.2K – 862
2021
Q3 		$12.2K Hold
178
– – ﹤0.01% 900
2021
Q2 		$12.1K Buy
+178
New +$12.6K ﹤0.01% 915

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

RBC Europe's IART Position: Q4 2021 in Review

RBC Europe sold out of Integra LifeSciences (IART) in Q4 2021, closing a stake of 178 shares — an estimated $12.2K sold.

RBC Europe first reported a position in IART in Q2 2021 and held it in 2 quarters. The position peaked at $12.2K in Q3 2021. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

  • RBC Europe reported no remaining Integra LifeSciences position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 178 Integra LifeSciences shares in Q4 2021, an estimated $12.2K.
  • RBC Europe first reported a position in Integra LifeSciences in Q2 2021 and held it in 2 quarters.
  • RBC Europe's Integra LifeSciences position peaked at $12.2K in Q3 2021.
  • 277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.